14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026
ABTS vs IPOD: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 16, 2026, IPOD (IPOD) is the stronger overall head-to-head candidate over Abits Group Inc (ABTS) in the Tradestie Institutional Equity Comparison Engine, winning 9–0 core matrix metrics and 2–2 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality). ABTS carries a Unified Composite Score of 48.4/100 (HOLD) at $0.33 (N/M Forward P/E, -46.3% operating margin), whereas IPOD carries 58.0/100 (HOLD) at $10.42 (N/M Forward P/E, 0.0% operating margin).
Technical & Structure Timing Caution: ABTS is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 16.8); meanwhile IPOD trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI N/A). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ABTS vs IPOD. Trailing 12-month operating profitability (ABTS -46.3% vs IPOD 0.0%) and valuation multiples (ABTS N/M vs IPOD N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Shell Companies value chain with $210.0M market capitalization and 0.0% operating margin.
OpEx & R&D ReinvestmentN/A
90D Engineering Disclosures0 Published
Investor FAQ ABTS vs IPOD Key Questions & Quantitative Answers
As of Nov 16, 2026, IPOD (IPOD) is the stronger overall head-to-head candidate over Abits Group Inc (ABTS) in the Tradestie Institutional Equity Comparison Engine, winning 9–0 core matrix metrics and 2–2 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality). ABTS carries a Unified Composite Score of 48.4/100 (HOLD) at $0.33 (N/M Forward P/E, -46.3% operating margin), whereas IPOD carries 58.0/100 (HOLD) at $10.42 (N/M Forward P/E, 0.0% operating margin). Technical & Structure Timing Caution: ABTS is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 16.8); meanwhile IPOD trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI N/A). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
IPOD leads the Growth & Scale pillar: ABTS posts -20.0% YoY revenue growth and +0.0% YoY earnings growth on $8.3M TTM revenue (23.7% gross margin, -46.3% operating margin), compared with IPOD at +0.0% YoY revenue growth and +0.0% YoY earnings growth on N/A TTM revenue (N/A gross margin, 0.0% operating margin). On trailing 12-month operating scale, ABTS generates $8.3M in USD-normalized revenue versus N/A for IPOD. In operating R&D and SG&A reinvestment, ABTS deploys 70.0% of Rev ($5.8M) (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for IPOD.
ABTS and IPOD trade at balanced relative valuation multiples. ABTS trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 0.4x EV/Revenue (0.9% EBITDA margin), whereas IPOD trades at N/M Forward P/E, 39.9x Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against ABTS (-60.0% ROE) versus IPOD (0.0% ROE) capital efficiency.
In options market volatility and institutional positioning, ABTS carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.73β · 224% Vol realized risk). By comparison, IPOD carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.00β · 2% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.